Focal adhesion kinase (pp125 FAK) is localized to focal adhesions and tyrosine phosphorylated by the engagement of 61 integrins. However, it is unclear how pp125 rAK is linked to integrin molecules. We demonstrate that pp125 FAK is directly associated with paxillin, a 68-kD cytoskeleton protein. The COOH-terminal domain ofppl25 FAK spanning FAK residues 919-1042 is sufficient for paxillin binding and has vinculin-homologous amino acids, which are essential for paxillin binding. Microinjection and subsequent imrnunohistochemical analysis reveal that glutathione S-transferase-FAK fusion proteins, which bind to paxillin, localize to focal adhesions, whereas fusion proteins with no paxillin-binding activity do not localize to focal adhesions. These findings strongly suggest that pp125 FAK is localized to focal adhesions by the direct association with paxillin.
Summary
Focal adhesion kinase (pp125 FAK) is localized to focal adhesions and tyrosine phosphorylated by the engagement of 61 integrins. However, it is unclear how pp125 rAK is linked to integrin molecules. We demonstrate that pp125 FAK is directly associated with paxillin, a 68-kD cytoskeleton protein. The COOH-terminal domain ofppl25 FAK spanning FAK residues 919-1042 is sufficient for paxillin binding and has vinculin-homologous amino acids, which are essential for paxillin binding. Microinjection and subsequent imrnunohistochemical analysis reveal that glutathione S-transferase-FAK fusion proteins, which bind to paxillin, localize to focal adhesions, whereas fusion proteins with no paxillin-binding activity do not localize to focal adhesions. These findings strongly suggest that pp125 FAK is localized to focal adhesions by the direct association with paxillin.
t h•at 1 integrins, also known as very late activation antigens, constitute a subfamily of integrin adhesion receptors is comprised by at least nine o~ subunits sharing a common [31 subunit (1, 2) . [31 integrins function as cell-surface receptors for extracellular matrix protein (ECM) 1 and also mediate cell-to-cell interaction (1, 2) . The marked changes in morphology and behavior that occur when cells interact with ECM through their integrins suggest that these receptors can function as transducers of extracellular signals into cells (2, 3) . Several laboratories including ours have shown that [31 integrins synergize with the TCR-CD3 pathway to promote T cell proliferation (4) (5) (6) . [31 integrins are also reported to be involved in T or B cell differentiation through interaction with fibronectin expressed by stromal cells in thymus or bone marrow, respectively (7, 8) . Furthermore, it was also reported that integrin-ECM binding induced increases of cytoplasmic Ca 2+ and cytoplasmic pH (9, 10) . These facts strongly support the notion that the interaction between [31 integrins and ECM transmits signals into the interior of cells.
In an effort to clarify mechanisms ofT cell costinmlatory signals mediated by [31 integrins, we found that tyrosine kinase activation might be a key event in this process. We showed that tyrosine phosphorylation of 105-130-kD proIAbbreviations used in this paper: ECL, enhanced chemiluminescence; ECM, extracellular matrix protein; FAT, focal adhesion targeting; FN, fibronectin; FRNK, FAK-related nonkinase; GST, glutathione S-transferase; PBS-T, PBS containing 0.1% Tween 20; PBS1, paxillin-binding subdomain 1; PBS2, paxillin-binding subdomain 2; pp 125 yAK, focal adhesion kinase; PTK, protein tyrosine kinase.
teins was induced by the ligation of [31 or ci4 integrin subunits using either fibronectin (FN) or mAbs in human peripheral T cells and H9, a T lymphoblastoid cell line (11, 12) . Several independent studies also showed that tyrosine phosphorylation of proteins in the range of 120-130 kD is induced by the engagement of [31 integrins in different types of cells including mouse fibroblasts and human epidermal cancer cell line (13, 14) . One of these tyrosinephosphorylated proteins was identified as the Wrosine kinase, focal adhesion kinase (pp125 FAK) (15, 16) .
pp125 F^K was first identified as a putative substrate for the oncogenic retrovirus gene product pp60 ..... (17) . Deduced amino acid sequence revealed FAK to be a novel cytoplasmic tyrosine kinase having relatively low homology to other known kinases and lacking SH2 and SH3 domains (15) . pp125 FAK is localized to focal adhesions (15) , which are the sites where cells adhere to the substrata via integrin-ECM binding. Subsequently, pp125 F^K was shown to be tyrosine phosphorylated by the ligation of [31 integrins (18, 19) . Since integrins lack an intrinsic protein tyrosine kinase (PTK) activity, these findings about pp125 F^K strongly suggest important roles of ppl25 F^K in the [31 integrin-mediated signaling. However, the nature of the interaction between [31 integrins and pp125 F^K remains unclear.
FAK-related nonkinase (FRNK), an autonomously expressed COOH-terminal non-catalytic domain ofppl25 r^K, was reported to be localized to focal adhesions (20) , suggesting that pp125 FAK COOH-terminal region plays an important role in the focal adhesion targeting (FAT) of pp125 yAK. Moreover, Hildebrand et al. reported that the FAT domain ofppl25 FAK, which is responsible for pp125 F^K localization to focal adhesions, is located in the COOHterminal region of pp125 F^K (21) . pp125 F^K and FRNK were reported to be coprecipitated with paxillin, a 68-kD cytoskeletal protein that is localized to focal adhesions (22, 23) . However, to date, the precise association ofppl25 F^K via its FAT domain with other molecules and the functional consequence of such association remain unresolved.
In this study, we demonstrate that pp125 F^K is directly associated with paxillin, yet tyrosine phosphorylations of pp125 FAK and paxillin are not necessary for this association. The paxiUin-binding domain of pp125 F^K that we have identified is homologous to the paxillin-binding domain of vinculin (24) . Mutations in the conserved amino acid residues between pp125 F^K and vinculin result in the loss of paxillin-binding activity. The relevance between paxillinbinding activity and FAT ofppl25 FAre is presented by using various deletion and substitution mutants ofppl25 ~^K.
Materials and Methods
Cell (18, 25) . In this article, the number of FAK amino acid indicated the number of 1,052 amino acids open-reading frame for the convenience of readers to compare with other publications.
Plasrnids that coded GST fusion proteins were constructed by the insertion of human FAK cDNA fragments into pGEX-2T or pGEX-3X (Pharrnacia Biotech Inc., Piscataway, NJ). Insert DNA fragnnents for deletion mutants were developed by appropriate restriction enzymes or by PCR with specific primers flanked with BamHl site (5' primer) and with EcolLl site (3' primer). Substitution mutants were generated by PCR to substitute one amino acid residue of the GST-FAK fusion protein containing residues 896-1052 (26) . JM 105 cells carrying plasmids were inoculated in the presence of 0.1 mM isopropyl-[3-D-thiogalactopyranoside to express GST-FAK fusion proteins. Cells were collected by centrifuge, resuspended in NETN buffer (20 mM Tris-HCl, pH 8.0, 100 mM NaC1, l mM EDTA, 0.5% NP-40), sonicated, and incubated with BSA-blocked glutathione-Sepharose 4B (Pharmacia Biotech. Inc.). After incubation, beads were washed with NETN buffer and subjected to precipitation. lmmunoprecipitation and Immunoblotting. To establish 10G2 mAb, the GST-FAK fusion protein containing FAK residues 706-1052 was used as the antigen and the source for screening hybridoma. Culture supernatant or ascites of 10G2 mAb were purified by protein G (Pierce, Rockford, IL).
For immunoprecipitation, cells were lysed in 1% NP-40 lysis buffer. Cellular lysates were incubated overnight with rotation in the cold room with glutathione-Sepharose conjugated with GST-FAK fusion proteins or antiphosphotyrosine mAb-conjugated beads (4G10, Upstate Biotechnology, Inc., Lake Placid, NY). Otherwise, cellular lysates were incubated overnight with first antibodies and then with goat anti-mouse IgG Ab-conjugated beads (Sigma Chemical Co.) for 4 h with rotation in the cold room. Beads were washed with 1% NP-40 washing buffer (1% NP-40, 50 mM Tris-HC1, pH 8.0, 140 mM NaC1, and 2.5 mM EDTA) five times. Washed beads were boiled 5 rnin at 100~ in the presence of 2% SDS and 0.1 M dithiothreitol, and supernatants of boiled samples were loaded onto SDS-polyacrylamide gels. For the second imrnunoprecipitation, washed beads were boiled 5 rain at 100~ in the presence of 1% SDS, and the supernatants were precipitated with antibodies in the 1% NP-40 washing buffer containing 0.1% SDS.
For immunoblotting, samples were subjected to electrophoresis in 7.5% polyacrylamide gels containing 0.1% SDS, electrotransferred onto nitrocellulose membranes (BioBlot; Costar Corp., Cambridge, MA), and blocked for 2 h with PBS containing 3% BSA at room temperature. After blocking, membranes were incubated with 0.1 I.zg/ml first antibodies in PBS containing I% BSA, washed in PBS containing 0.l% Tween 20 (PBS-T), incubated with horseradish peroxidase-conjugated sheep antimouse IgG Ab (I 0,000 times dilution) in PBS-T, washed in PBS-T, and analyzed by the enhanced chemiluminescence (ECL) system (Amersharn Corp., Arlington Heights, 1L). In the case of 12SI-labeled antibodies, membranes were incubated overnight in the cold room with 125I-labeled antiphosphotyrosine mAb (4G10, kindly provided by Brian Druker, Dana-Farber Cancer Institute, Boston, MA) or 10G2 mAb in PBS-T, were washed in PBS-T, and were subjected to autoradiography. The method used in ~251-labeling of antibodies was described elsewhere (1 l). Membranes were reprobed with other antibodies after reblocking. For overlay assay, GST-FAK fusion protein containing FAK residues 706-1052 was IzsI labeled by the same method and used instead of radiolabeled antibodies.
Microinjection and 1mmunofluorescence. GST-FAK fusion proteins were washed on beads with PBS, eluted from beads by the elution solution (20 mM glutathione, 50 mM Tris-HCl, final pH 8.0), and dialyzed with DMEM. Microinjection was perfonued based on the syringe-loading method described by Clarke and McNeil (27) . Swiss 3T3 cells were trypsinized, collected by centrifugation, resuspended in 200-300 I~1 DMEM containing 2 rag/ ml GST-FAK fusion proteins and 0.5% wt/vol Pluronic F-68 (Sigma Chemical Co.). Cells were passed through hypodermic needles (30G; Hamilton Co., Reno, NV) 30 times, collected by centrifugation, and incubated overnight on a cover slip in 5% FCS--supplemented DMEM. For immunostaining, cells were fixed and immersed with PBS containing 3.7% formaldehyde and PBS containing 0.2% Triton X-100. Cells were then incubated with first antibodies in PBS (antipaxillin mAb, 1:50, or anti-GST mAb, 1:100), washed with PBS, incubated with FITC-conjugated goat anti-mouse IgG Ab (Tago, Inc., Burlingame, CA) in PBS (1:50), washed, and subjected to analysis with fluoromicroscopy (Axioskop; Carl Zeiss, Inc., Thornwood, NY).
Results

Identification of a Tyrosine-phosphorylated 70-kD pp125 FaKassociated Protein as Paxillin.
It is now established that one of the major substrates for integrin-mediated tyrosine phosphorylation is pp125 F~, a 125-kD cytoplasmic PTK. Furthermore, our recent studies indicated that the solid-phase cross-linking of 131 integrin by antibodies or its ligand FN stimulated tyrosine phosphorylation of several additional proteins, such as 140, 110-130, 70, 55-60, and 45 kD in peripheral T cells (27a) and in a T lymphoblastoid cell line, HPB-ALL (data not shown). To determine the relationship between pp125 FAK and these other proteins, we attempted to define pp125FAK-associated molecules. For this purpose, lysates of HPB-ALL cells with or without FN stimulation were precipitated with the anti-FAK mAb (10G2) or with the GST fusion protein containing pp125 rAK C O O H -t e rminal region residues 706-1052, and were analyzed by immunoblotting with antiphosphotyrosine mAb. As shown in Fig. 1 , tyrosine-phosphorylated pp125 F~K was well precipitated with 10G2 mAb, whereas no additional tyrosinephosphorylated proteins were detected by precipitation with 10G2 mAb (lane 6). However, a 70-kD protein, which was precipitated by the GST-FAK fusion protein from the lysate of FN-stimulated HPB-ALL cells, was clearly detected by immunoblotting with antiphosphotyrosine mAb ( Fig. 1 A, lane 8) . This 70-kD protein was not detected by antiphosphotyrosine mAb blotting in the absence of FN stimulation ( Fig. 1 A, lane 4) . These results suggest the following: (a) a 70-kD protein is tyrosine phosphorylated by FN stimulation in HPB-ALL cells; (b) this 70-kD protein (pp70) binds to FAK protein, although it is not clear whether tyrosine phosphorylation of this protein is required for binding to pp125 F~. Tyrosine phosphorylation in the binding site of pp125 F~ is not necessary for pp70 binding, because the GST-FAK fusion protein, which was not phosphorylated on tyrosine residues, bound to pp70. This tyrosine-phosphorylated 70-kD protein was also detected in H9 cells and Jurkat cells as well as peripheral T cells by the ligation of 131 integrins (data not shown). In addition to lymphoid ceils, pp70 was also detected in nonlymphoid adherent cell lines such as T-47D, a human breast cancer cell line (Fig. 1 B, lane 4) . Given that preincubation of the GST-FAK fusion protein with the 10G2 mAb essentially blocked precipitation of pp70 (data not shown), it was conceivable that 10G2 mAb competed with pp70 for binding to pp125 FAK.
To identify the pp70 protein, pp70 was precipitated with the GST-FAK fusion protein, fractionated by SDS-PAGE, and analyzed by immunoblotring with specific antibodies against candidate proteins for pp70. As shown in Fig. 2 A, we found that paxillin was precipitated with GST-FAK fusion protein from HPB-ALL cell lysates with or without FN stimulation, as well as from T-47D cell lysate, and it migrated with a mobility similar to pp70, suggesting that pp70 was identical to the tyrosine-phosphorylated paxillin. It was also determined that tyrosine phosphorylation of paxillin was induced by the ligation of [31 integrins in HPB-ALL cells (data not shown) and in peripheral T cells (27a) . To confirm that pp70 was paxillin, pp70 was precipitated by the GST-FAK fusion protein from T-47D cell lysate, solubilized by boiling in buffer containing 1% SDS, reprecipitated with antiphosphotyrosine mAb or antipaxillin mAb, and analyzed by immunoblotting with antipaxillin mAb (Fig. 2 B) and with antiphosphotyrosine mAb (Fig. 2  C) . Tyrosine-phosphorylated pp70, which was precipitated with the GST-FAK fusion protein, was detected by antipaxilhn mAb (Fig. 2 B, lane 4) , and tyrosine-phosphorylated paxillin (Fig. 2 C, lanes 1 and 5) migrated with exactly the same mobility as pp70 (Fig. 2 C, lanes 2 and 4) . Similar results were obtained in FN-stimulated HPB-ALL cells (data not shown). These results confirm that pp70 is paxillin. Comparison of Fig. 2 , B and C, (lanes 2 and 5) showed that non-tyrosine-phosphorylated paxillin was precipitated with the GST-FAK fusion protein as well as pp70, tyrosine-phosphorylated paxillin. Furthermore, the paxillin protein that was precipitated with the GST-FAK fusion protein from HPB-ALL cell lysate without FN stimulation was not tyrosine phosphorylated ( Fig. 1 A, lane 4, and Fig.   2 A, lane 2) . These results strongly suggest that tyrosine phosphorylation of paxillin is not required for the binding to pp125 FAK.
Direct Association of pp 125 FAK with Paxillin. Although the association of the GST-FAK fusion protein with paxillin was demonstrated, the following points remained unclear: (a) Is endogenous pp125 FAK associated with paxiUin? (b) Is paxillin directly associated with pp125 F^K or associated indirectly via binding to other proteins? To define whether endogenous pp125 F^K protein was associated with paxillin, HPB-ALL and T-47D cell lysates were immunoprecipitated with antipaxillin mAb and analyzed by immunoblotring. As shown in Fig. 3, A and B, pp125 F^K was coprecipitated with paxillin by antipaxillin mAb (lanes 1-3) . The amounts of coprecipitated pp125 FAK appear to be almost the same with or without FN stimulation (Fig. 3 A, lanes 1  and 2) . Although paxillin was not coprecipitated with pp125 F^K by 10G2 mAb (Fig. 3 B, lane 4) , it should be noted that paxillin was coprecipitated with another anti-FAK mAb (Transduction Laboratories, Lexington, KY), which recognized a different epitope of FAK from 10G2 rnAb (data not shown). These data further suggest that 10G2 mAb competes with paxillin for binding to pp125 F~a~. pp125 FAK was also coprecipitated with crk, an adapter protein composed of SH2 and SH3 domains (28), using anti-crk mAb in T-47D cells (Fig. 3 A, lane 5) .
To determine whether the association between pp125 ~AK and paxillin was direct or indirect, we next performed overlay assay using 125I-labeled GST-FAK fusion protein as a probe. Immunoprecipitated paxillin was analyzed by overlay assay with 125I-labeled GST-FAK fusion protein. As shown in Fig. 4 A, a protein of 68 kD was detected by 12sI-labeled GST-FAK fusion protein on the lanes of precipitates with antipaxillin mAb (lanes 1 and 2), whereas no protein was detected using control precipitations (lanes 3 and 4). This protein had the same mobility as paxillin by reprobing of the membrane with anti-paxillin mAb (Fig. 4 
Identification of Paxillin-binding Domain of pp125 FAK. T o determine the paxillin-binding d o m a i n of pp125 FAK, we developed several deletion mutants derived from the G S T -F A K fusion protein. H P B -A L L cell lysates were incubated
with these deletion mutant proteins, precipitated, and analyzed by i m m u n o b l o t t i n g with antipaxillin mAb. As s h o w n in Fig. 5 A, G S T fusion protein containing pp125 rAK a m i n o acid residues 7 0 6 -1 0 5 2 and 9 0 3 -1 0 5 2 retained paxillin-binding activity, whereas fusion proteins containing FAK residues 7 0 6 -9 9 7 and 9 0 3 -9 9 7 did n o t b i n d to paxillin. These results indicate that the paxillin-binding domain is located in pp125 FAK residues 903-1052. T o define the paxillin-binding domain o f pp125 F^K more precisely, we developed additional deletion mutants of the G S T -F A K fusion protein by PC1K and performed the paxillin-binding assay with these mutants. As s h o w n in Fig. 5 C, deletion mutants containing pp125 v^K residues 896-1047, 8 9 6 -1052, 903-1052, and 9 1 9 -1 0 5 2 precipitated paxillin, while mutants containing F A K residues 896-1038, 939-1052, 903-997, 896-1005, 896-1015, 896-1027, and 9 6 7 -1 0 5 2 did not precipitate paxillin. T h e amounts of the m u t a n t proteins used for precipitation are shown in Fig. 5 E. F r o m precipitation analysis with deletion mutants s h o w n in Fig. 5 and the additional mutants (summarized in Table 1 ), we conclude that pp125 FAK residues 9 1 9 -1 0 4 2 are sufficient for mutants with a deletion that corresponds to human pp125 FaK residues 861-967 or 969-1016 resulted in the loss of FAT (21) . Since these two mutants have deletions in the paxillin-binding domain, these mutants are expected to lack paxillin-binding activity, suggesting the relevance between paxillin-binding activity and FAT of ppl25 FAK. To determine the 10G2 mAb epitope, the same membranes used in Fig. 5 , A and C, were reprobed with 12SI-labeled 10G2 mAb. As shown in Fig. 5, B and D, the epitope of 10G2 mAb was mapped within pp125 FAK residues 939-1038, indicating that the epitope of 10G2 mAb is located within the paxillin-binding domain ofppl25 FAK.
Identification of pp 125 yAK Amino Acid Residues Essential for
PaxiUin Binding. PaxiUin was first identified as a vinculinbinding protein (23) . Vinculin, a ll6-kD cytoskeleton protein, is also localized at focal adhesions, and the paxillinbinding domain of vinculin was identified recently (24) . Chick vinculin residues 881-1000 are sufficient for paxillin binding, and vinculin residues 979-1000 are critical for paxillin binding. To determine the role of these homologous amino acid residues in the interaction with paxillin, we generated substitution mutants within pp125 v^K residues 896-1052 and performed paxillin-binding analysis with these mutant proteins. As shown in Fig. 7 A, substitutions of either residue 928 Val to Gly, 931 Leu to Arg, and 935 Val to Ala in PBS1 resulted in a significant decrease in paxillin-binding activity, whereas substitutions of 923 Lys to Glu, 929 Thr to Ala or Ser, and 933 Lys to Glu had no effect on paxillin binding. In PBS2, substitutions of 1034 Leu to Ser, 1035 Leu to Ala, 1037 Val to Asp, 1039 Glu to Ala, and 1042 Arg to Gly significantly decreased paxillinbinding activity, whereas 1033 Asn to Asp, 1036 Glu to Biological Relevance between the Paxillin Binding and the FATofpp125 FAK. Given that the paxillin-binding domain and the FAT domain ofppl25 Fmr overlap each other, one of the putative biological functions of ppl25 ~ta~ binding to paxiUin would be the recruitment ofppl25 Fta~ to focal adhesions. To elucidate this possibility, we performed immunohistochemical analysis combined with microinjection of GST-FAK fusion proteins. The GST-FAK fusion protein containing FAK residues 706-1052 (GST-FAK 706-1052) was microinjected into 3T3 Swiss albino cells by the syringe-loading method (27) and analyzed by immunostaining with anti-GST mAb and FITC-labeled anti-mouse IgG Ab. As shown in Fig. 8 , C and D, microinjected GST-FAK 706-1052 was detected at focal adhesions and localized at the ends ofactin stress fibers by double staining with rhodamine-labeled phailoidine (Fig. 8 E) . Depending on the efficiency ofmicroinjection (shown in Fig. 8 B) , GST-FAK 706-1052 was not detected in all cells (Fig. 8 C) , although endogenous paxillin was detected at focal adhesions in all cells (Fig. 8 A) as well as endogenous pp125 F^r~ and vinculin (data not shown). Microinjected GST protein, which did not contain a pp125 r peptide, was not detected at focal adhesions (Fig. 8 F) . Next, the FAT of the deletion mutants of GST-FAK fusion proteins was determined by the same method. GST-FAK fusion proteins containing pp125 rta~ residues 896-1052 (Fig. 8 H) and 919-1052 (Fig. 8J) , which had binding activity to paxillin, were localized to focal adhesions, whereas GST-FAK fusion proteins containing FAK residues 706-904 (Fig. 8 G) , 896--1038 (Fig. 8 /) , and 939-1052 (Fig. 8 K) , which had no binding activity to paxillin, were not localized to focal adhesions. These results indicate that pp125 F~a~ residues 919-1052 are sufl]cient for the FAT of FAK. For further study of the role of paxillin binding in the FAT of pp125 ~^K, similar analysis was performed using substitution mutants of GST-FAK 896--1052. GST-FAK mutants containing substitutions of 928 Gly (data not shown), 931 Arg (Fig. 8 L) , and 1034 Ser (Fig. 8 M] were not localized to focal adhesions, whereas substitution mutants carrying 923 Glu (data not shown), 1036 His (Fig. 8 N) , and 1043 Arg (data not shown) were localized to focal adhesions. These results, summarized in Table 1 , clearly depict the relevance between paxillin-binding activity and FAT activity of pp125 F^K, indicating that pp125 Fta~ localizes to focal adhesions by its direct interaction with paxillin. 
1095
Tachibana et al.
Discussion
pp125 FAre colocalizes with 13l integrins at focal adhesions, where cells attach to the extracellular matrix (15, 19) . The complex architecture of cellular focal adhesions depends on numerous protein-protein interactions between focal adhesion components. However, the mechanisms and cellular components regulating various aspects of signaling induced by integrins are unclear.
Our previous results indicated that the ligation of 131 integrins induces tyrosine phosphorylations of 140-, 110--130-, 70-, 55--60-, and 45-kD proteins. Some of these proteins have been identified to be phospholipase C 7, PP 125F^K, paxillin, pp59 fx~, and pp56 ~ck, and MAP kinase in peripheral T cells (27a). Since 131 integrins lack an intrinsic PTK activity, these protein tyrosine phosphorylations strongly suggest the presence of a PTK(s), which is functionally linked to 131 integrins, pp125 F^K is a prime candidate for such PTKs, since FAK is colocalized with 131 integrins at focal adhesions (15) . pp125 F^K is also tyrosine phosphory- Paxillin was first identified as a 6 8 -k D vinculin-binding protein localized to focal adhesions (23) . Paxillin is phosphorylated on both serine/threonine and tyrosine residues (19) . Paxillin has four L I M domains in its C O O H -t e r m i n a l region that are flanked by a unique NH2-terrninal region, and it lacks SH2 and SH3 domains (22) . Tyrosine phosphorylation of paxillin is invariably accompanied by the tyrosine phosphorylation of pp125 F^K, suggesting a close relationship between pp125 FA~( and paxillin (19, 36) . Turner and Miller recently showed that pp125 F~ was precipitated with the GST-paxillin fusion protein (22) , although it was not clarified whether pp125 FAK was directly associated with paxillin and whether pp125 r^K was localized to focal adhesions by the association with paxillin. We have shown that paxillin is directly associated with GST fusion protein containing pp125 F^K residues 706-1052 by peptide-to-peptide interaction and that posttranslational modifications are not involved in pp125F^K-paxillin association. Endogenous pp125 F^K is also coprecipitated with paxillin, indicating the in vivo association between pp125 F^K and paxillin. The engagement ofintegrins and the subsequent tyrosine phosphorylation of pp125 r^a and paxillin appear to have no effect on this association, since the amount of ppl25 FAK coprecipitated with paxillin and the amount of ppl25 FAK in the insoluble fraction were not altered by the ligation of [31 integrins in HPB-ALL cells (Fig. 2 A and our unpublished data) . The pp125 r^K residues 919-1042 were determined to be sufficient for the association of pp125 F^K with paxillin. This paxillin-binding domain ofppl25 F^K shares sequence similarity with the paxillin-binding domain of vinculin, and substitutions of conserved amino acids resulted in the loss ofpaxillin-binding activity. Most of the essential amino acids for paxillin binding are leucine and valine, which are amino acids with hydrophobic side chains and which are involved in the formation of tertiary structures and/or a hydrophobic pocket(s), pp125 FA~ residue 1039 Glu has a carboxyl group, which is essential for paxillin binding, since the substitution of this glutamate residue to alanine resulted in a significant decrease ofpaxillin-binding activity. Despite lacking homology with vinculin sequence, 1042 Arg also appears to be essential for paxillin binding. These two paxillin domains of pp125 F^K and vinculin share homologous amino acids, although they also have several differences. In pp125 F^K, two paxillin-binding subdomains are separated by the insertion of 98-amino acid sequence, while PBS1 and -2 are closely located in vinculin. A putative binding site of PI3 kinase 85-kD subunit is located in this insertion sequence of pp125 F^K (37) , and the GRB2-binding site of pp125 FAK, which included 925 Tyr, is located in the FAK PBS1 (33) . These two binding sites for PI3 kinase and GRB2 are not located in vinculin PBS1, suggesting a difference between pp125 FAK and vinculin in downstream signalings.
The biological relevance between the paxillin-binding activity and the FAT activity ofppl25 FAK was clearly demonstrated by the immunohistochemical analysis of the cells microinjected with GST-FAK fusion proteins. Deletion and substitution mutants with paxillin-binding activity are localized to focal adhesions, whereas mutants without paxillin-binding activity are not localized to focal adhesions. These findings indicate that pp125 ~AK is localized to focal adhesions by the association with paxillin. Focal adhesions, where cells attach to substrata via integrin-ECM binding, are also composed of cytoskeletal proteins such as talin, vinculin, paxillin, FP,.NK, and pp125 rAa (19, 38) . Among these proteins, vinculin, which has a conserved paxillinbinding domain with pp125 FAK, appears to be localized to focal adhesions by the association with paxillin (24) , and talin is associated with vinculin (39). Our findings strongly suggest that pp125 FAK and other proteins are localized to focal adhesions and linked to [31 integrins via the interaction with paxillin. It remains to be clarified how pp125 F^K and paxillin are tyrosine phosphorylated by the ligation of [31 integrins. The interaction with paxillin appears not to be sufficient for tyrosine phosphorylation ofppl25 FAK, since non-tyrosine-phosphorylated pp125 FA~ is associated with paxillin in HPB-ALL cells without the ligation of [31 integrins. On the other hand, the induction of pp125 r^K tyrosine phosphorylation is much stronger by the solid-phase cross-linking of [31 integrins on plates than by the crosslinking in liquid phase (our unpublished data). This finding suggests that focal adhesion formation and FAT ofppl25 rAK via paxillin play a crucial role in [31 integrin-mediated tyrosine phosphorylation of pp 125 F^K.
In summary, pp125 F^K is associated with paxillin and localized to focal adhesions via paxiUin. [31 integrin-ligand ligation induces FAT, and tyrosine phosphorylation of pp125 FAK then induces recruitment of signaling molecules to tyrosine-phosphorylated pp125 F^K, which presumably results in [31 integrin-mediated cell adhesion, cytoskeleton organization, and cell proliferation.
